Clinical trial
Modulation of Molecular Fingerprinting in Pediatric Sepsis
NCT02055105 is registered in ClinicalTrials.gov with Phoenix Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Molecular Fingerprinting in Pediatric Sepsis
- Lead sponsor
- Phoenix Children's Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 31, 2014
- Completion date
- October 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.